000522SZSE

2012 Annual Report of Independent Directors

Baiyunshan A Co., Ltd.·February 28, 2013·4 pages

✨ AI Summary

This report outlines the performance of independent directors at Guangzhou Baiyunshan Pharmaceutical Holdings in 2012. Key activities included attending 13 board meetings and issuing independent opinions on significant matters such as audit appointments and asset restructuring. The independent directors emphasized their commitment to protecting shareholder rights, particularly for minority shareholders, and maintaining effective communication with the management team.

Summary generated by AI · Always verify with source document

Full Translation

AI Translation· azure_openai

Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd. 2012 Annual Report of Independent Directors

In 2012, the independent directors of the company strictly adhered to the Company Law, the Guidelines for Establishing Independent Directors in Listed Companies, and other relevant regulations, as well as the Articles of Association. They faithfully fulfilled their duties, diligently performed their responsibilities, and fully leveraged the role of independent directors to further safeguard the overall interests of the company and protect the legitimate rights and interests of all shareholders, especially minority shareholders. The following is the report on the performance of independent directors in 2012:

I. Attendance at Meetings

In 2012, the company held a total of 13 board meetings, with the attendance of independent directors as follows:

Independent Director	Number of Meetings to Attend	In-Person Attendance	Proxy Attendance
Wen Xu	13	11	2
Zhu Guilong	13	13	0
Yi Xusheng	13	13	0

Free accounts get 10 full releases per month. Pro subscribers get unlimited access.